• No results found

Angiotensin receptor

Molecular modeling of angiotensin type 1 receptor for angiotensin receptor blockers

Molecular modeling of angiotensin type 1 receptor for angiotensin receptor blockers

... (AT1) receptor, belong to the family of ...of angiotensin receptor blockers ensin II binds to the AT1 receptor within the transmembrane domains in an extended conformation, and its C-terminal ...

5

Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review

Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review

... Introduction: Heart failure is a debilitating disease with increasing prevalence worldwide and often treated with angiotensin- converting enzyme inhibitors (ACEi) or angiotensin receptor blockers ...

5

Assessment of adverse drug reactions of angiotensin converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) among sudanese patients

Assessment of adverse drug reactions of angiotensin converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) among sudanese patients

... with angiotensin converting enzyme (ACE) inhibitors prevents progression from micro albuminuria to overt nephropathy, and in overt nephropathy decreases the gradual loss of renal function beyond its blood pressure ...

5

Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ mediated signaling

Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ mediated signaling

... the angiotensin receptor blocker (ARB) olmesartan has been shown to attenuate bone loss in ovariectomized hypertensive rats and to inhibit Ang II stimulation of receptor activator of nuclear factor ...

19

Observational study of brain atrophy and cognitive decline comparing a sample of community dwelling people taking angiotensin converting enzyme inhibitors and angiotensin receptor blockers over time

Observational study of brain atrophy and cognitive decline comparing a sample of community dwelling people taking angiotensin converting enzyme inhibitors and angiotensin receptor blockers over time

... 896 (88) N/A 888 (83) 906 (88) 893 (86) 873 (75) n (%) n (%) n (%) n (%) n (%) n (%) Female sex 44 (55) 5 (4) 28 (60) 21 (45) 19 (54) 9 (75) ApoE4 carrier 17 (21) 4 (29) 11 (23) 10 (21) 8 (23) 3 (25) Type 2 diabetes 33 ...

28

Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date

Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date

... and angiotensin-receptor inhibitor that has been developed for use in heart ...the angiotensin-receptor blocker ...an angiotensin-converting enzyme inhibitor (enalapril) in reducing ...

13

Evaluation of G2350A Polymorphism of the Angiotensin-Converting Enzyme (ACE) Gene in Chronic Kidney Disease

Evaluation of G2350A Polymorphism of the Angiotensin-Converting Enzyme (ACE) Gene in Chronic Kidney Disease

... 17. Chang, H.R., Cheng, C.H., Shu, K.H., Chen, C.H., Lian, J.D., Wu, M.Y. Study of the polymorphism of angiotensinogen, angiotensin- converting enzyme and angiotensin receptor in type II diabetes ...

5

Aliskiren and valsartan combination therapy for the management of hypertension

Aliskiren and valsartan combination therapy for the management of hypertension

... an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker (ARB), plus a calcium channel blocker or thiazide diuretic are the most effective, well-tolerated, and proven ...

12

The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol

The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol

... and angiotensin receptor blockers/direct renin inhibitors, for instance, preserve tubular blood flow and may prevent the tubular injury that charac- terises the transition from reversible pre-renal AKI to ...

6

Journal homepage: www.ijptjournal.com A PROSPECTIVE OBSERVATIONAL STUDY ON MANAGEMENT OF HYPERTENSION IN PATIENTS ON HEMODIALYSIS

Journal homepage: www.ijptjournal.com A PROSPECTIVE OBSERVATIONAL STUDY ON MANAGEMENT OF HYPERTENSION IN PATIENTS ON HEMODIALYSIS

... • Interestingly, we observed that Hypertension were cured in majority of patients following the treatment with calcium channel blockers, central agonists, alpha1 blockers, beta blockers, angiotensin ...

5

Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date

<p>Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date</p>

... of Angiotensin Receptor–Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) trial demonstrated ...

8

First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination

First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination

... Abstract: Arterial hypertension is one of the major diseases in the Western world. It is an independent cardiovascular risk factor and is associated with increased morbidity and mortality. Several drug classes have been ...

8

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study

... ACE-I: Angiotensin converting enzyme inhibitor; AJCC: American Joint Committee on Cancer; AngII: Angiotensin II; ARB: Angiotensin receptor blocker; BB: Beta blocker; BMI: Body mass index; CAD: ...

9

“A Class Review on ACE Inhibitors/ARBS and Beta Blockers and Effectiveness in HFrEF” by Rakhi K R, Dhandapani Chidambaram, Aleena Alex, Ann Merry Davis, Bharathi K, Keerthanaa B, India.

“A Class Review on ACE Inhibitors/ARBS and Beta Blockers and Effectiveness in HFrEF” by Rakhi K R, Dhandapani Chidambaram, Aleena Alex, Ann Merry Davis, Bharathi K, Keerthanaa B, India.

... Angiotensin receptor blockers inhibit the renin– angiotensin–aldosterone system (by preventing the binding of angiotensin II to its receptor, which in turn leads to vasoconstriction and ...

5

SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease

SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease

... peptide-1 receptor agonists, miner- alocorticoid receptor antagonists, and especially the angiotensin-converting enzyme inhibitors/angiotensin receptor ...

11

Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria

Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria

... ACE-inhibitors: angiotensin-converting enzyme inhibitors; ADR: adverse drug reaction; ARB: angiotensin receptor blockers; AT2-antagonists: angiotensin II receptor antagonists; BPSD: Beha[r] ...

11

Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial

Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial

... of angiotensin II, by either ACE inhibition or angiotensin receptor blockade, improves insulin activation of the PI3K pathway, thus facilitating Glut-4 translocation and glucose uptake in ...

8

Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies

Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies

... Abbreviations ACE: Angiotensin-converting enzyme; ACh: Acetylcholine; AIA: Adjuvantinduced arthritis; ANG-II: Angiotensin II; ARB: Angiotensin receptor blocker; BH4: Tetrahydrobiopterin;[r] ...

8

Utility of untimed single urine protein/creatinine ratio as a substitute for 24 h proteinuria for assessment of proteinuria in systemic lupus erythematosus

Utility of untimed single urine protein/creatinine ratio as a substitute for 24 h proteinuria for assessment of proteinuria in systemic lupus erythematosus

... ACE: Angiotensin-converting enzyme; ACR: American College of Rheumatology; ARB: Angiotensin receptor blocker; CCC: Concordance correlation coefficient; CI: Confidence interval; ExC: Expected ...

9

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies

... A population-based estimate of ACEI-AEs has not been published before. The annual (1st-year) cumula- tive incidence of angioedema among ACEI users is fairly stable, as the meta-analyses of the randomized controlled ...

9

Show all 10000 documents...

Related subjects